FATE - Fate Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FATE is currently covered by 18 analysts with an average price target of $10.02. This is a potential upside of $8.33 (492.9%) from yesterday's end of day stock price of $1.69.

Fate Therapeutics's activity chart (see below) currently has 176 price targets and 146 ratings on display. The stock rating distribution of FATE is 6.67% SELL, 62.22% HOLD and 31.11% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.49% with an average time for these price targets to be met of 118.62 days.

Highest price target for FATE is $10, Lowest price target is $5, average price target is $10.02.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 17-Jun-2024.

Currently out of the existing stock ratings of FATE, 3 are a SELL (6.67%), 28 are a HOLD (62.22%), 14 are a BUY (31.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$6

$4.17 (227.87%)

$4

6 months 1 days ago
(17-Jun-2024)

18/24 (75%)

$2.43 (68.07%)

254

Buy

$9

$7.17 (391.80%)

$16

7 months 8 days ago
(10-May-2024)

0/3 (0%)

$4.92 (120.59%)

Hold

$6

$4.17 (227.87%)

$7

7 months 8 days ago
(10-May-2024)

3/7 (42.86%)

$1.92 (47.06%)

88

Hold

$5

$3.17 (173.22%)

$7

7 months 8 days ago
(10-May-2024)

8/11 (72.73%)

$0.92 (22.55%)

143

Sell

$6

$4.17 (227.87%)

$4

8 months 20 days ago
(28-Mar-2024)

2/3 (66.67%)

$-1.34 (-18.26%)

111

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FATE (Fate Therapeutics) average time for price targets to be met?

On average it took 118.62 days on average for the stock forecasts to be realized with a an average price target met ratio 63.49

Which analyst has the current highest performing score on FATE (Fate Therapeutics) with a proven track record?

MATTHEW BIEGLER

Which analyst has the most public recommendations on FATE (Fate Therapeutics)?

Matthew Biegler works at OPPENHEIMER and has 12 price targets and 7 ratings on FATE

Which analyst is the currently most bullish on FATE (Fate Therapeutics)?

Michael Schmidt with highest potential upside - $105.17

Which analyst is the currently most reserved on FATE (Fate Therapeutics)?

Matthew Biegler with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?